BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,017,383 | +208.8% | 148,523 | +250.3% | 0.00% | – |
| Q2 2023 | $329,433 | -60.6% | 42,398 | -36.8% | 0.00% | – |
| Q4 2022 | $836,262 | -5.5% | 67,062 | -2.2% | 0.00% | – |
| Q3 2022 | $885,000 | +20.1% | 68,595 | -2.0% | 0.00% | – |
| Q2 2022 | $737,000 | -40.8% | 70,022 | -7.5% | 0.00% | – |
| Q1 2022 | $1,244,000 | +95.3% | 75,685 | +63.9% | 0.00% | – |
| Q4 2021 | $637,000 | -55.9% | 46,190 | -51.0% | 0.00% | -100.0% |
| Q3 2021 | $1,446,000 | +74.0% | 94,173 | +78.5% | 0.00% | – |
| Q2 2021 | $831,000 | +38.3% | 52,767 | -8.8% | 0.00% | – |
| Q1 2021 | $601,000 | -2.6% | 57,849 | -29.5% | 0.00% | – |
| Q4 2020 | $617,000 | +578.0% | 82,079 | +216.4% | 0.00% | – |
| Q3 2020 | $91,000 | -47.1% | 25,941 | -16.7% | 0.00% | – |
| Q2 2020 | $172,000 | +8500.0% | 31,129 | +2453.7% | 0.00% | – |
| Q1 2020 | $2,000 | -97.1% | 1,219 | -93.9% | 0.00% | – |
| Q4 2019 | $68,000 | +119.4% | 19,898 | +86.6% | 0.00% | – |
| Q3 2019 | $31,000 | -20.5% | 10,662 | +4.3% | 0.00% | – |
| Q2 2019 | $39,000 | +387.5% | 10,219 | +921.9% | 0.00% | – |
| Q1 2019 | $8,000 | -60.0% | 1,000 | -60.7% | 0.00% | – |
| Q4 2018 | $20,000 | +42.9% | 2,544 | +45.0% | 0.00% | – |
| Q3 2018 | $14,000 | +40.0% | 1,754 | +3.2% | 0.00% | – |
| Q2 2018 | $10,000 | +100.0% | 1,699 | +69.9% | 0.00% | – |
| Q1 2018 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 1,000 | -42.3% | 0.00% | – |
| Q1 2016 | $5,000 | -72.2% | 1,732 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | -5.3% | 1,732 | 0.0% | 0.00% | – |
| Q3 2015 | $19,000 | +26.7% | 1,732 | +73.2% | 0.00% | – |
| Q2 2015 | $15,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $9,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $12,000 | +20.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $10,000 | -23.1% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $13,000 | +18.2% | 1,000 | 0.0% | 0.00% | – |
| Q1 2014 | $11,000 | +37.5% | 1,000 | 0.0% | 0.00% | – |
| Q4 2013 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
| ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
| Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
| Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
| TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
| Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
| AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
| Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
| Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |